• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods . Potential of Antibody Pair Targeting Conserved Antigenic Sites in Diagnosis of SARS-CoV-2 Variants Infection

tetano

Editor, Senior Moderator
J Virol Methods


. 2022 Aug 3;114597.
doi: 10.1016/j.jviromet.2022.114597. Online ahead of print.
Potential of Antibody Pair Targeting Conserved Antigenic Sites in Diagnosis of SARS-CoV-2 Variants Infection


Siling Wang[SUP] 1 [/SUP], Yangling Wu[SUP] 2 [/SUP], Yizhen Wang[SUP] 1 [/SUP], Zihao Chen[SUP] 1 [/SUP], Dong Ying[SUP] 1 [/SUP], Xue Lin[SUP] 1 [/SUP], Chang Liu[SUP] 1 [/SUP], Min Lin[SUP] 1 [/SUP], Jinlei Zhang[SUP] 1 [/SUP], Yuhe Zhu[SUP] 1 [/SUP], Shaoqi Guo[SUP] 1 [/SUP], Huixian Shang[SUP] 1 [/SUP], Xiuting Chen[SUP] 1 [/SUP], Hongsheng Qiang[SUP] 1 [/SUP], Yifan Yin[SUP] 1 [/SUP], Zimin Tang[SUP] 3 [/SUP], Zizheng Zheng[SUP] 4 [/SUP], Ningshao Xia[SUP] 5 [/SUP]



Affiliations
Free PMC article

Abstract

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has become disaster for human society. As the pandemic becomes more regular, we should develop more rapid and accurate detection methods to achieve early diagnosis and treatment. Antigen detection methods based on spike protein has great potential, however, it has not been effectively developed, probably due to the torturing conformational complexity. By utilizing cross-blocking data, we clustered SARS-CoV-2 receptor binding domain (RBD)-specific monoclonal antibodies (mAbs) into 6 clusters. Subsequently, the antigenic sites for representative mAbs were identified by RBDs with designed residue substitutions. The sensitivity and specificity of selected antibody pairs was demonstrated using serial diluted samples of SARS-CoV-2 S protein and SARS-CoV S protein. Furthermore, pseudovirus system was constructed to determine the detection capability against SARS-CoV-2 and SARS-CoV. 6 RBD-specific mAbs, recognizing different antigenic sites, were identified as potential candidates for optimal antibody pairs for detection of SARS-CoV-2 S protein. By considering relative spatial position, accessibility and conservation of corresponding antigenic sites, affinity and the presence of competitive antibodies in clinical samples, 6H7-6G3 was rationally identified as optimal antibody pair for detection of both SARS-CoV-2 and SARS-CoV. Furthermore, our results showed that 6H7 and 6G3 effectively bind to SARS-CoV-2 variants of concern (VOCs). Taken together, we identified 6H7-6G3 antibody pair as a promising rapid antigen diagnostic tool in containing COVID-19 pandemic caused by multiple VOCs. Moreover, our results also provide an important reference in screening of antibody pairs detecting antigens with complex conformation.

Keywords: COVID-19; ELISA; SARS-CoV-2; antibody pair; spike antigen.
 
Back
Top Bottom